The application of proton pump inhibitors in cardiovascular disease needs to be individualized

Cardiovasc Drugs Ther. 2022 Dec;36(6):1247-1248. doi: 10.1007/s10557-022-07395-z. Epub 2022 Oct 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / drug therapy
  • Humans
  • Proton Pump Inhibitors* / adverse effects

Substances

  • Proton Pump Inhibitors